间歇性氯胺酮与神经调控治疗产生协同抗抑郁相关作用
该临床前研究在小鼠中检验电惊厥刺激(ECS)与氯胺酮是否按剂量和给药间隔产生协同抗抑郁相关效应。结果显示,间歇(24小时间隔)给予亚有效剂量的氯胺酮与ECS可产生类似有效剂量氯胺酮的协同突触与行为抗抑郁效果,且不损害认知;同时给药则无协同效应。
要点
- 间歇(24小时间隔)亚有效剂量氯胺酮与ECS可协同产生抗抑郁样突触和行为效应。
- 间歇联合给药不损害认知,而重复ECS则不然。
- 氯胺酮与ECS同时给药时协同效应被阻止。
核心结论
- 氯胺酮与ECS表现出时间敏感的抗抑郁样协同作用,提示靶向谷氨酸能突触metaplasticity可在增强、加速和延长抗抑郁效果的同时减少副作用。
研究设计与样本
- 研究采用行为药理学与离体海马脑片电生理方法,在成年小鼠中检验ECS与氯胺酮按剂量和给药间隔产生协同抗抑郁相关效应的假说。
主要发现
- 重复氯胺酮而非ECS导致海马Schaffer collateral-CA1突触突触增强幅度增大的metaplasticity。
- 间歇(24小时间隔)给予单个亚有效剂量的氯胺酮与ECS产生协同抗抑郁样突触和行为结果,类似有效剂量氯胺酮的作用。
- 与重复ECS不同,间歇氯胺酮与ECS给药产生抗抑郁相关突触和行为作用而不损害认知。
- 单独氯胺酮的抗抑郁样效应在与单次ECS治疗间歇给药时被延长。
- 氯胺酮与ECS同时给药时协同效应被阻止。
临床怎么用
- 临床前结果提示,靶向谷氨酸能突触metaplasticity的间歇联合策略可能减少副作用并增强、加速和延长抗抑郁效果。
局限性
- 研究为临床前小鼠模型,结论外推至临床精神心理科实践需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Historically, the most effective antidepressant is electroconvulsive therapy (ECT). ECT induces cognitive side effects and commonly requires numerous treatments over several weeks for robust symptom relief. The rapid response that can be observed following ketamine treatment has led to a reconceptualization of how pharmacotherapy can treat depression. One subanesthetic infusion can alleviate symptoms within hours; however, sustained relief also requires multiple doses. Clinical studies have combined ECT and ketamine to improve therapeutic outcomes but have yielded mixed results. METHODS: We used behavioral pharmacology and ex vivo hippocampal slice electrophysiology to test the hypothesis that a preclinical ECT model, electroconvulsive stimulation (ECS), and ketamine can exert synergistic antidepressant-relevant effects in adult mice dependent on dose and dose interval. RESULTS: Repeated doses of ketamine, but not ECS, led to a metaplasticity characterized by an increased magnitude of synaptic potentiation at the hippocampal Schaffer collateral-CA1 synapse. Targeting ketamine-induced metaplasticity intermittently (i.e., 24-hour interval) by delivering individual, subeffective ketamine and ECS doses produced synergistic antidepressant-like synaptic and behavioral outcomes that resembled the actions of an effective ketamine dose. Unlike repeated ECS, intermittent ketamine and ECS administration yielded antidepressant-relevant synaptic and behavioral actions without impairing cognition. Antidepressant-like effects produced by ketamine alone were prolonged when intermittently administered with an individual ECS treatment. Synergistic effects were precluded when ketamine and ECS were delivered concurrently. CONCLUSIONS: Ketamine and ECS exhibited time-sensitive, synergistic antidepressant-like actions, suggesting that strategies targeting metaplasticity at glutamatergic synapses can be used to reduce side effects while augmenting, accelerating, and prolonging antidepressant outcomes.
引用
- Brown KA, Gould TD. Intermittent Ketamine and Neuromodulation Treatment Evoke Synergistic Antidepressant-Relevant Action. Biol Psychiatry. 2025. PMID: 41110745. doi:10.1016/j.biopsych.2025.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。